Features | B | SE | Wald | Sig. | Exp (B) | 95.0% CI for Exp (B) | |
---|---|---|---|---|---|---|---|
OS | |||||||
Clinicopathological stages | 1.508 | 0.281 | 28.846 | < 0.001 | 4.517 | 2.605 | 7.832 |
β-catenin | 1.738 | 0.667 | 6.787 | 0.009 | 5.687 | 1.538 | 21.030 |
TCF4 | 1.515 | 0.619 | 5.993 | 0.014 | 4.548 | 1.353 | 15.293 |
Survivin | 1.499 | 0.555 | 7.289 | 0.007 | 4.479 | 1.508 | 13.300 |
EBV-VCA-IgA | 2.607 | 0.779 | 11.190 | 0.001 | 13.562 | 2.944 | 62.482 |
EBV-EA-IgA | 2.476 | 0.486 | 25.986 | < 0.001 | 11.890 | 4.590 | 30.803 |
DMFS | |||||||
Clinicopathological stages | 1.873 | 0.283 | 43.663 | < 0.001 | 6.508 | 3.734 | 11.343 |
β-catenin | 2.334 | 0.753 | 9.610 | 0.002 | 10.321 | 2.359 | 45.146 |
TCF4 | 2.145 | 0.562 | 14.544 | < 0.001 | 8.538 | 2.836 | 25.707 |
EBV-EA-IgA | 0.766 | 0.349 | 4.806 | 0.028 | 2.151 | 1.085 | 4.268 |
LRFS | |||||||
Family history | 1.181 | 0.282 | 17.512 | < 0.001 | 3.257 | 1.873 | 5.663 |
N stage | 0.736 | 0.195 | 14.232 | < 0.001 | 2.087 | 1.424 | 3.058 |
Clinicopathological stages | 1.230 | 0.219 | 31.463 | < 0.001 | 3.421 | 2.226 | 5.257 |
TCF4 | 1.754 | 0.521 | 11.323 | 0.001 | 5.776 | 2.080 | 16.041 |
EBV DNA | 1.393 | 0.464 | 9.008 | 0.003 | 4.028 | 1.622 | 10.004 |
EBV-EA-IgA | 1.162 | 0.343 | 11.497 | 0.001 | 3.198 | 1.633 | 6.261 |
DFS | |||||||
Clinicopathological stages | 1.639 | 0.203 | 65.080 | < 0.001 | 5.150 | 3.458 | 7.669 |
β-catenin | 1.232 | 0.484 | 6.470 | 0.011 | 3.429 | 1.327 | 8.863 |
TCF4 | 1.635 | 0.540 | 9.163 | 0.002 | 5.131 | 1.780 | 14.793 |
Survivin | 1.039 | 0.464 | 5.011 | 0.025 | 2.826 | 1.138 | 7.016 |
EBV DNA | 1.396 | 0.351 | 15.780 | < 0.001 | 4.039 | 2.028 | 8.042 |
EBV-VCA-IgA | 1.467 | 0.335 | 19.171 | < 0.001 | 4.336 | 2.249 | 8.362 |
EBV-EA-IgA | 1.239 | 0.275 | 20.293 | < 0.001 | 3.452 | 2.014 | 5.919 |